⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19523377 | 1.00 | TDP1 (0.36) | — | |
| SCHEMBL2103164 | 0.89 | — | — | |
| SCHEMBL5412906 | 0.79 | TDP1 (0.36) | — | |
| SCHEMBL11109724 | 0.78 | TDP1 (0.33) | — | |
| SCHEMBL3298704 | 0.78 | — | — | |
| SCHEMBL45517 | 0.78 | — | — | |
| SCHEMBL1469789 | 0.76 | TDP1 (0.32) | — | |
| SCHEMBL11500857 | 0.74 | — | — | |
| SCHEMBL6277553 | 0.74 | — | — | |
| SCHEMBL7176719 | 0.73 | KMT2A (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 806 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3544613-B1 | GSK-3 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2021-06-09 | — | — | EP | claimed |
| US-10752609-B2 | GSK-3 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-08-25 | — | — | US | claimed |
| US-20190315714-A1 | GSK-3 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2019-10-17 | — | — | US | claimed |
| EP-3544613-A1 | GSK-3 INHIBITORS | Bristol-Myers Squibb Company (US) | 2019-10-02 | — | — | EP | claimed |
| WO-2018098412-A1 | GSK-3 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-31 | — | — | WO | claimed |
| EP-3066093-B9 | GSK-3 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-02-07 | — | — | EP | claimed |
| EP-2229134-B1 | CONCENTRATED PERSONAL CLEANSING COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-11-15 | — | — | EP | claimed |
| EP-3066093-B1 | GSK-3 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-10-04 | — | — | EP | claimed |
| US-9718804-B2 | GSK-3 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-08-01 | — | — | US | claimed |
| US-20160272621-A1 | GSK-3 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-09-22 | — | — | US | claimed |
| EP-1277741-A1 | CYCLIC COMPOUNDS | TANABE SEIYAKU CO., LTD. (JP) | 2003-01-22 | — | — | EP | claimed |
| US-20030008407-A1 | Non-invasive diagnostic and monitoring system based on odor detection | FU CHI YUNG (US) | 2003-01-09 | — | — | US | claimed |
| EP-1066261-A1 | PYRIDINE DERIVATIVE AND PHARMACEUTICAL CONTAINING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2001-01-10 | — | — | EP | claimed |
| WO-1999048871-A1 | PYRIDINE DERIVATIVE AND PHARMACEUTICAL CONTAINING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-30 | — | — | WO | claimed |
| EP-0921125-A1 | 1,3,8-Triaza-spiro 4,5 decan-4-on derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1999-06-09 | — | — | EP | claimed |
| US-5041454-A | Stimulate gastrointestinal motility | JANSSEN PHARMACEUTICA N.V. (BE) | 1991-08-20 | — | — | US | claimed |
| CN-87102879-A | Benzhydryl compounds as herbicide antidotes | — | 1987-10-28 | — | — | CN | claimed |
| CN-86106435-A | Imidazolinyl derivative, its preparation method and the preparation that contains this compounds with herbicide effect | — | 1987-05-27 | — | — | CN | claimed |
| US-4484009-A | HYDROGENOLYSIS USING 2-ALKYL-1,3-DIOXOLANE | ATOCHEM (FR) | 1984-11-20 | — | — | US | claimed |
| US-4390710-A | A 4-AMINOPYRIDINE WITH A PYRIDINE | PPG INDUSTRIES, INC. (US) | 1983-06-28 | — | — | US | claimed |